The global radiopharmaceutical theranostics market was valued at around USD 2.73 billion in 2024 and is expected to grow at a CAGR of 13.8%. Growth is driven by the rising prevalence of cancer and increasing demand for precision medicine worldwide. https://www.expertmarketresearch.com/reports/radiopharmaceutical-theranostics-market